Serbian Nanocraft Only Startup That Deals with Early Diagnostics of Cardiovascular Diseases
Comments
Illustration (Photo: Africa Studio/shutterstock.com)
At the beginning of his interview for Netokracija, Maksim pointed out that each biotech startup required expert staff, adequate laboratory space and, of course, financing.
Due to the confidentiality of the project and the Law on Protection of Intellectual Property Maksim couldn’t reveal too much about the product itself. The only thing he could say was that it was a diagnostics method for an early detection of cardiovascular diseases, the kind of which had not been present in the local or the international market.
The effectiveness and the quickness of the realization of the ideas was helped to a great extent by the Faculty of Pharmacy, as the key partner of Nanocraft. TS Ventures Fund of Telekom Srbija has included it among the nine local innovative companies on whose development they will work in the coming period.
Companies:
Nanocraft d.o.o. Beograd
Farmaceutski fakultet Univerziteta u Beogradu
Alternativni investicioni fond TS VENTURES FOND d.o.o. Beograd
Tags:
Nanocraft
Faculty of Pharmacy
TS Ventures Fund Telekom Srbija
Maksim Baković
biochemistry
cardiovascular diseases
cardiovascular disease diagnostics
early detection of cardiovascular diseases
biotech startups
Comments
Your comment
Naš izbor
Most Important News
Full information is available only to commercial users-subscribers and it is necessary to log in.
Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno,
uz konsultacije sa našim ekspertima.